Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.4070
+0.0100 (2.52%)
At close: Nov 6, 2026
Farmacosmo Revenue
Farmacosmo had revenue of 18.75M EUR in the half year ending June 30, 2026, a decrease of -43.41%. This brings the company's total for the last twelve months to 46.74M, down -21.29% year-over-year. In the year 2025, Farmacosmo had annual revenue of 56.26M, down -12.44%. That makes Farmacosmo the 27,727th largest company in the world by revenue and 233rd in Italy.
Revenue (ttm)
46.74M
Revenue Growth
-21.29%
P/S Ratio
0.34
Revenue / Employee
811.04K
Employees
57
Market Cap
15.80M
Revenue by Geography
- Italy 51.13M 98.4%
- European Union 852.60K 1.6%
Fiscal year ended Dec 31, 2025 See the full Farmacosmo breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.26M | -8.00M | -12.44% |
| Dec 31, 2024 | 64.26M | -8.35M | -11.50% |
| Dec 31, 2023 | 72.61M | 5.97M | 8.96% |
| Dec 31, 2022 | 66.64M | 8.14M | 13.92% |
| Dec 31, 2021 | 58.50M | 14.01M | 31.51% |
| Dec 31, 2020 | 44.48M | 20.17M | 82.96% |
| Dec 31, 2019 | 24.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.41B |
| DiaSorin | 1.18B |
| EL.En. | 611.40M |
| GPI S.p.A. | 543.23M |
| Svas Biosana | 141.74M |
| Talea Group | 132.17M |
| EuKedos | 52.91M |